A

Almirall
ALM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
€2.35B
EV
€2.32B
Shares Outstanding
214.79M
Beta
0.29

Wall Street View

Analyst Rating
BUY
Analyst Target Price
€12.13
P/E 2025E
45.33x
P/Revenue 2025E
2.13x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Almirall, S.A.

gainify

A

Almirall, S.A.

ALM

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onych...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Gallardo Piqué, Carlos

Employees

2,026

IPO Date

2007-06-20

Headquarters

Ronda General Mitre, 151, Barcelona, Catalonia, 08022, Spain

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.